Abstract
Context
Chemsex involves mental and sexual health risks for users, which generate specific needs in primary care. The aim of this study is to evaluate the role of the general practitioner (GP) in the identification of disorders and first aid offered to MSM chemsex users (CUs).
Methods
Data were collected with a self-administered questionnaire offered to MSM patients consulting in six Parisian STI clinics. The primary endpoint was the number of GP visits reported by patients in the past 12 months between CUs and control.
Results
Three hundred sixty-four MSMs were included between October and December of 2018: 94 CUs (25.9%) and 270 control. The multivariate analysis showed no statistically significant difference in the number of GP visits in the past 12 months (3.27 vs 2.66, p = 0.205). CUs had a higher number of sexual partners (p < 0.001) and used PrEP more often (OR 3.33 [CI95% 1.81–6.22]). Among the CUs, 67% had consulted their GP for STI testing in the last 12 months and 29.7% for PrEP. About 28.3% had ever mentioned their chemsex practices at GP and 10.9% had taken sick leaves at least once.
Conclusion
Our study explored the impact of chemsex on the demand for care at GP. There is an association of chemsex with PrEP.
Policy Implications
The relays of PrEP and chemsex care in general practice in the coming years require an awareness from health professionals. The management of chemsex complications should be extended into care networks and include GPs.
Similar content being viewed by others
References
Antidote: Drugs & Alcohol Support. (n.d.). London Friend. Retrieved May 3, 2021, from https://londonfriend.org.uk/antidote-drugs-alcohol/
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
Batisse, A., Grégoire, M., Marillier, M., Fortias, M., & Djezzar, S. (2016). Cathinones Use in Paris. L’encephale, 42(4), 354–360.
Batisse, A., Peyrière, H., Eiden, C., Courné, M-A., Djezzar, S. (2016). Usage de psychostimulants dans un contexte sexuel: Analyse des cas rapportés au Réseau français des centres d’addictovigilance. Évaluation des risques liés à la pratique du SLAM. Thérapie, 71(5), 447–455.
Billioti De Gage, S. Aubriere, S., Dray-Spira, R. (2018). Suivi de l’utilisation de Truvada ou génériques pour une prophylaxie pré-exposition (PrEP) au VIH. ANSM, (p.20)
Bourne, A., Reid, D., Hickson, F., Torres Rueda, S., & Weatherburn, P. (2014). The Chemsex Study: Drug use in sexual settings among gay and bisexual men in Lambeth, Southwark & Lewisham. Sigma Research. (p. 72)
Brancourt, M. (2016, t). Sexe et drogues, le nouveau deal. Remaides, 96, 34–38.
Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine, 158(16), 1789–95.
Closson, E. F., Mitty, J. A., Malone, J., Mayer, K. H., & Mimiaga, M. J. (2018). Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: A qualitative study. AIDS Care, 30(2), 191–198.
Desai, M., Bourne, A., Hope, V., & Halkitis, P. N. (2018). Sexualised drug use: LGBT communities and beyond. International Journal of Drug Policy, 55, 128–130.
Dolengevich-Segal, H., Prado, M., Rodríguez-Salgado, B., & Ballesteros-López, J. (2017). Chemsex. An emergent phenomenon. Adicciones, 29(3), 207–209.
Evers, Y. J., Hoebe, C. J. P. A., Dukers-Muijrers, N. H. T. M., Kampman, C. J. G., Kuizenga-Wessel, S., Shilue, D., Bakker, N. C. M., Schamp, S. M. A. A., Van Buel, H., Van Der Meijden, W. C. J. P. M., & Van Liere, G. A. F. S. (2020). Sexual, addiction and mental health care needs among men who have sex with men practicing chemsex - a cross-sectional study in the Netherlands. Preventive Medicine Reports., 18, 101074.
Foureur, N., Fournier, S., Jauffret-Roustide, M., Labrouve, V., Pascal, X., Quatremère, G., Rojas-Castro D. (2013). SLAM - Première enquête qualitative en France. AIDES. (p.58)
Giorgetti, R., Tagliabracci, A., Schifano, F., Zaami, S., Marinelli, E., & Busardò, F. P. (2017). When “Chems” Meet Sex: A Rising Phenomenon Called “ChemSex.” Current Neuropharmacology, 15(5), 762–770.
Gonzalez, A., & Nutt, D. J. (2005). Gamma hydroxy butyrate abuse and dependency. Journal of Psychopharmacology, 19(2), 195–204.
Gosset, D., L’Yavanc, T., & Ohayon, M. (2016). Evaluation de la consommation de substances psychoactives chez les usagers d’un centre de santé sexuelle juin 2016.
Graf, N., Dichtl, A., Deimel, D., Sander, D., & Stöver, H. (2018). Chemsex among men who have sex with men in Germany: Motives, consequences and the response of the support system. Sexual Health, 15(2), 151–156.
Hegazi, A., Lee, M. J., Whittaker, W., Green, S., Simms, R., Cutts, R., Nagington, M., Nathan, B., & Pakianathan, M. R. (2017). Chemsex and the city: Sexualized substance use in gay bisexual and other men who have sex with men attending sexual health clinics. International Journal of STD & AIDS, 28(4), 362–366.
Heiligenberg, M., Wermeling, P. R., van Rooijen, M. S., Urbanus, A. T., Speksnijder, A. G. C. L., Heijman, T., Prins, M., Coutinho, R. A., & van der Loeff, M. F. S. (2012). Recreational drug use during sex and sexually transmitted infections among clients of a city sexually transmitted infections clinic in Amsterdam, the Netherlands. Sexually Transmitted Diseases, 39(7), 518–527.
Hunter, L. J., Dargan, P. I., Benzie, A., White, J. A., & Wood, D. M. (2014). Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM. Postgraduate Medical Journal, 90(1061), 133–138.
Karila, L., & Reynaud, M. (2011). GHB and synthetic cathinones: clinical effects and potential consequences. Drug Testing Analysis, 3(9), 552–559.
Kenyon, C., Wouters, K., Platteau, T., Buyze, J., & Florence, E. (2018). Increases in condomless chemsex associated with HIV acquisition in MSM but not heterosexuals attending a HIV testing center in Antwerp. Belgium. AIDS Research and Therapy, 15(1), 14.
Liechti, M. E., Kunz, I., Greminger, P., Speich, R., & Kupferschmidt, H. (2006). Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug and Alcohol Dependence, 81(3), 323–326.
Ma, R., & Perera, S. (2016). Safer ‘chemsex’: GPs’ role in harm reduction for emerging forms of recreational drug use. The British Journal of General Practice, 66(642), 4–5.
Melendez-Torres, G. J., Hickson, F., Reid, D., Weatherburn, P., & Bonell, C. (2017). Findings from within-subjects comparisons of drug use and sexual risk behaviour in men who have sex with men in England. International Journal of STD & AIDS, 28(3), 250–258.
Milhet Maitena, & Néfau Thomas. (2017). Chemsex, Slam, Renouvellement des usages de drogues en contextes sexuels parmis les HSH. Théma TREND, OFDT (p. 32).
Mont, M. (2014). Out of our mind: Improving provision of drug & alcohol treatment for lesbian, gay, bisexual & trans people.
Pakianathan, M., Whittaker, W., Lee, M. J., Avery, J., Green, S., Nathan, B., & Hegazi, A. (2018). Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Medicine, 19(7), 485–490.
Pollard, A., Nadarzynski, T., & Llewellyn, C. (2018). Syndemics of stigma, minority-stress, maladaptive coping, risk environments and littoral spaces among men who have sex with men using chemsex. Culture, Health & Sexuality, 20(4), 411–427.
Potherat, G., Tassel, J., & Epaulard. (2019). Homogen: Perception par les patients de la modification de la relation médecin patient après mention de l’orientation sexuelle. Bulletin Epidemiologique Hebdomadaire, 12, 204–210.
Prosser, J. M., & Nelson, L. S. (2012). The toxicology of bath salts: A review of synthetic cathinones. Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology, 8(1), 33–42.
R Core Team (2018). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/
Richard, B. (2014). Treatment seekin among gay men currently or previously taking part in chemsex [MSc Tesis in Addiction studies]. Kings College London.
Rosińska, M., Gios, L., Nöstlinger, C., Vanden Berghe, W., Marcus, U., Schink, S., Sherriff, N., Jones, A.-M., Folch, C., Dias, S., Velicko, I., Mirandola, M., & Network, S. I. I. (2018). Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey. The International Journal on Drug Policy, 55, 231–241.
Roux, P., Fressard, L., Suzan-Monti, M., Chas, J., Sagaon-Teyssier, L., Capitant, C., Meyer, L., Tremblay, C., Rojas-Castro, D., Pialoux, G., Molina, J.-M., & Spire, B. (2018). Is on-demand HIV pre-exposure prophylaxis a suitable tool for men who have sex with men who practice chemsex? Results from a substudy of the ANRS-IPERGAY Trial. Journal of Acquired Immune Deficiency Syndromes (1999), 79(2), e69–e75.
Sewell, J., Cambiano, V., Miltz, A., Speakman, A., Lampe, F. C., Phillips, A., Stuart, D., Gilson, R., Asboe, D., Nwokolo, N., Clarke, A., Hart, G., & Rodger, A. (2018). Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013–2016. Sexually Transmitted Infections., 94(7), 494–501.
Skryabin, V. Y., Khoryaev, D., & Torrado, M. (2020). Changes in sexual behavior patterns due to stimulants use: three case reports. Journal of Addictive Diseases, 38(3), 375–379.
Talec, J.-Y. L., & Linard, F. (2015). Plaisirs chimiques: Sexualité et usage de drogues chez des hommes gais séropositifs. Psychotropes, 21(2), 157–182.
Thai, D., Dyer, J. E., Benowitz, N. L., & Haller, C. A. (2006). GHB and ethanol effects and interactions in humans. Journal of Clinical Psychopharmacology, 26(5), 524–529.
The EMIS Network. (2019) EMIS-2017 – The European Men-Who-Have-Sex-With-Men Internet Survey. Key findings from 50 countries. Stockholm: European Centre for Disease Prevention and Control, p.179
Van Acker, J. (2018). Plan chem ? Plan Slam ? Les plans « sous prod » : une recherche exploratoire sur le chemsex parmi les gays, bisexuels et autres HSH dans la Région de Bruxelles-capitale. Observatoire du sida et des sexualités.
Velter, A., Sauvage, C., Saboni, L., Sommen, C., Alexandre, A., Lydié, N., Peytavin, G., Barin, F., & Lot, F. (2017). Estimation de la prévalence du VIH chez les hommes ayant des relations sexuelles avec des hommes fréquentant les lieux de convivialité gay de cinq villes françaises – PREVAGAY 2015. Bulletin Épidémiologique Hebdomadaire, 18, 347–354.
Winstock, A., Mitcheson, L., Ramsey, J., Davies, S., Puchnarewicz, M., & Marsden, J. (2011). Mephedrone: Use, subjective effects and health risks. Addiction (abingdon, England), 106(11), 1991–1996.
WHO Assist Working Group. (2002). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction, 97(9), 1183–1194.
Zeggagh, J., Brun, A., Siguier, M., & Molina, J.-M. (2020). Knowledge and practices of Parisian family physicians for the management of men who have sex with men in the era of HIV pre-exposure prophylaxis. Médecine Et Maladies Infectieuses, 50(7), 597–605.
56 Dean Street. (n.d.). 56 Dean Street. Retrieved May 3, 2021, from https://dean.st/fr/
Author information
Authors and Affiliations
Contributions
Dorian Rollet, M.D.: conceptualization-equal; data curation-equal; formal analysis-lead; investigation-lead; methodology-lead; resources-equal; writing—original draft-equal. Virgile Clergue-Duval, M.D.: formal analysis-supporting; writing—review and editing-supporting. Sébastien Fouéré, M.D. MSc: conceptualization-supporting; project administration-equal; writing—review and supervision-supporting. Christophe Segouin, M.D.: conceptualization-supporting and project administration-equal. Anne Simon, M.D.: project administration-equal and supervision-supporting. Michel Ohayon, M.D.: conceptualization-supporting; project administration-equal, supervision-supporting, writing—review and editing-supporting. Amélie Aim-Eusebi, M.D.: conceptualization-supporting; methodology-supporting; supervision-lead; writing—review and editing-lead.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rollet, D., Clergue-Duval, V., Fouéré, S. et al. Chemgen Study: Assessing the Consumption of Care in General Practice of Men with Sexual Relationships with Men Users of Psychoactive Products in a Sexual Context. Sex Res Soc Policy 19, 1080–1089 (2022). https://doi.org/10.1007/s13178-021-00600-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13178-021-00600-y